Ponoi Management, LLC
- SEC CIK
- 0001720702
- Latest filing
- Nov 14, 2022
Holdings in Q2 2021
Holdings as of Jun 30, 2021, filed Aug 16, 2021. Long positions only; changes compare share counts with Q1 2021.
- Positions
- 5
- 0 vs. Q1 2021
- Portfolio value
- $180.0M
- +$9.96M (+5.9%) vs. Q1 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| CNSTConstellation Pharmaceuticals Inc | COM | 1,880,623 | $63.6M | 35.3% | 00.0% | Unchanged | History |
| RAPTRAPT Therapeutics, Inc. | COM | 1,599,417 | $50.8M | 28.3% | 00.0% | Unchanged | History |
| NGMNGM Biopharmaceuticals Inc | COM | 1,298,908 | $25.6M | 14.2% | 00.0% | Unchanged | History |
| RVMDRevolution Medicines, Inc. | COM | 685,011 | $21.7M | 12.1% | 00.0% | Unchanged | History |
| NRIXNurix Therapeutics, Inc. | COM | 686,274 | $18.2M | 10.1% | 00.0% | Unchanged | History |